Argent Trust Company’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q3
$4.72M Buy
158,435
+5,073
+3% +$163K 2.1% 11
2015
Q2
$4.88M Buy
153,362
+2,222
+1% +$72.4K 1.95% 11
2015
Q1
$4.99M Sell
151,140
-5,078
-3% -$161K 2.03% 9
2014
Q4
$4.62M Sell
156,218
-10,590
-6% -$304K 1.87% 11
2014
Q3
$4.68M Sell
166,808
-20,504
-11% -$575K 1.83% 12
2014
Q2
$5.27M Sell
187,312
-2,749
-1% -$78.4K 1.87% 12
2014
Q1
$5.79M Sell
190,061
-334
-0.2% -$9.96K 2.18% 9
2013
Q4
$5.53M Buy
190,395
+1,793
+1% +$52.2K 2.1% 10
2013
Q3
$5.14M Buy
188,602
+892
+0.5% +$24.3K 2.18% 11
2013
Q2
$4.99M Buy
+187,710
New +$5.19M 2.21% 9

Other funds holding PFE

Argent Trust Company's PFE Position: Q3 2015 in Review

Argent Trust Company increased its Pfizer (PFE) stake by 3.3% in Q3 2015, buying an estimated $163K and bringing the position to 158,435 shares worth $4.72M. The position accounts for 2.1% of the portfolio, ranked #11.

Argent Trust Company first reported a position in PFE in Q2 2013 and has held it in 10 quarters since. The position peaked at $5.79M in Q1 2014. 1,880 funds tracked by Wall St. Rank hold PFE as of Q3 2015.

  • Argent Trust Company held 158,435 shares of Pfizer worth $4.72M as of Q3 2015.
  • Argent Trust Company bought 5,073 Pfizer shares in Q3 2015, an estimated $163K.
  • Pfizer made up 2.1% of Argent Trust Company's portfolio in Q3 2015, its #11 holding.
  • Argent Trust Company first reported a position in Pfizer in Q2 2013 and has held it in 10 quarters since.
  • Argent Trust Company's Pfizer position peaked at $5.79M in Q1 2014.
  • 1,880 funds tracked by Wall St. Rank held Pfizer as of Q3 2015.

Based on Argent Trust Company's 13F filing for Q3 2015, filed 13 Nov 2015.